<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Diverse human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> with poor prognosis, including many lymphoid and <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid malignancies</z:e>, exhibit high levels of Mcl-1 </plain></SENT>
<SENT sid="1" pm="."><plain>To explore the impact of Mcl-1 overexpression on the hematopoietic compartment, we have generated vavP-Mcl-1 transgenic mice </plain></SENT>
<SENT sid="2" pm="."><plain>Their lymphoid and myeloid cells displayed increased resistance to a variety of cytotoxic agents </plain></SENT>
<SENT sid="3" pm="."><plain>Myelopoiesis was relatively <z:mpath ids='MPATH_458'>normal</z:mpath>, but lymphopoiesis was clearly perturbed, with excess mature B and T cells accumulating </plain></SENT>
<SENT sid="4" pm="."><plain>Rather than the follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> typical of vavP-BCL-2 mice, aging vavP-Mcl-1 mice were primarily susceptible to <z:hpo ids='HP_0002665'>lymphomas</z:hpo> having the phenotype of a stem/progenitor cell (11 of 30 tumors) or pre-B cell (12 of 30 tumors) </plain></SENT>
<SENT sid="5" pm="."><plain>Mcl-1 overexpression dramatically accelerated Myc-driven <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Most vavP-Mcl-1/ Eμ-Myc mice died around birth, and transplantation of blood from bitransgenic E18 embryos into unirradiated mice resulted in stem/progenitor cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, lethally irradiated mice transplanted with E13 fetal liver cells from Mcl-1/Myc bitransgenic mice uniformly died of stem/progenitor cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>When treated in vivo with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> coexpressing Mcl-1 and Myc transgenes were significantly more resistant than conventional Eμ-Myc <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Collectively, these results demonstrate that Mcl-1 overexpression renders hematopoietic cells refractory to many cytotoxic insults, perturbs lymphopoiesis and promotes <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> of hematopoietic stem and progenitor cells </plain></SENT>
</text></document>